Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about New gene therapy to treat spinal muscular atrophy
EMA has recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal muscular atrophy (SMA), a rare and often fatal genetic disease that causes muscle weakness and progressive loss of movement.
- Read more about Indian scientist designed potential vaccine candidate for new corona virus
Indian Researcher from University of Hyderabad has developed potential vaccine candidate for COVID-19 (novel corona virus). The potential vaccine candidate is active against all the structural and non-structural proteins of COVID-19.
- Read more about Daiichi Sankyo and Kitasato Pharma to terminate sales agreement of Influenza HA vaccine
Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. (hereinafter, “ Kitasato Pharmaceutical Industry”) announced the termination of their cooperative sales agreement for Influenza HA Vaccine “Daiichi Sankyo” 1 mL and Influenza HA Vaccine Syringe “Daiichi Sankyo” 0.25 mL and 0.5 mL on March 31, 2020 in Japan.
- Read more about AstraZeneca collaborate with Silence Therapeutics to discover, develop and commercialise small siRNA
AstraZeneca will collaborate with Silence Therapeutics to discover, develop and commercialise small interfering RNA (siRNA) therapeutics for the treatment of Cardiovascular, Renal, Metabolic and Respiratory diseases.
- Read more about Kidney patients are more vulnerable to COVID-19 infections
The COVID-19 pandemic is throwing up unique challenges for health systems. It presents particular challenges for patients who receive regular haemodialysis. These patients with damaged kidneys, also known as uremic patients, are particularly vulnerable to infection and may exhibit greater variations in clinical symptoms and infectivity.
- Read more about China restarts exports of pharma raw materials in India
China restarts the export of active pharmaceutical ingredients (APIs) and other raw materials from China to Indian Pharmaceutical industries reported by the BusinessLine. The import was halt by COVID-19 outbreak in China.
26 March 2020

PharmD professionals to join in the fight against COVID-19 in Karnataka

Pharm.D doctors and interns may join in the fight against COVID-19 (corona virus) in Karnataka reported by Karnataka State PharmD Doctors Association (KSPDA) to PharmaTutor
- Read more about Government approved package of Rs 13760 crore for APIs and medical devices
The cabinet has approved four schemes which totally include Rs 13,760 crore to promote the domestic production of active pharmaceutical ingredients (APIs) and medical devices in the country and their exports.
- Read more about China in trouble, USD 20 trillion lawsuit against China for spread of COVID-19
- Read more about Genentech announces FDA approval of Clinical Trial for Actemra to Treat Hospitalized Patients With Severe COVID-19 Pneumonia
Genentech, a member of the Roche Group announced the U.S. Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra® (tocilizumab) plus standard of care in hospitalized adult patients with severe COVID-19 pneumonia.